The trademark application GLANDITROPIN was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 17, 2000, and it was registered by office on October 10, 2000 without any oppositions.
The application was filed in German (English was selected as the second language).
Two renewals of the trademark were recorded, one on July 13, 2009, and the other one on March 25, 2019.
Change of name and address of the trademark registration was recorded on November 15, 2001. Change of name and professional address of the trademark registration was recorded on November 24, 2006. A transfer of the trademark registration was recorded on June 4, 2007. Change of name and address of the trademark registration was recorded on July 9, 2007. Change of name and address of the trademark registration was recorded on July 23, 2007. Change of name and professional address of the trademark registration was recorded on August 27, 2007. Change of name and address of the trademark registration was recorded on December 17, 2007. Change of name and professional address of the trademark registration was recorded on September 3, 2010. Change of name and professional address of the trademark registration was recorded on April 5, 2016. Change of name and address of the trademark registration was recorded on January 20, 2017. Change of name and address of the trademark registration was recorded on January 26, 2017. Change of name and address of the trademark registration was recorded on January 30, 2017. Change of name and address of the trademark registration was recorded on February 28, 2017.